September 2006
Central European Journal of Public Health;2006, Vol. 14 Issue 3, p112
Academic Journal
This article reports on the standards for registration of human medical research that were announced by the World Health Organization. This is part of the International Clinical Trials Registry Platform, an initiative aimed at standardizing the way information on medical studies is disclosed to the public. Concerned stakeholders that were consulted for the Registry Platform initiative included representatives from the pharmaceutical, biotechnology and device industries, patient and consumer groups, governments, medical journal editors, ethics committees, and academia.


Related Articles

  • Pharma Urged to Register Early Trials. Mitchell, Pete // Pharma DD: Tracking Discovery & Development;Jul/Aug2006, Vol. 1 Issue 1, p20 

    The article focuses on the proposal of the World Health Organization (WHO) concerning the publication of plans for all clinical trials by pharmaceutical companies on the Internet that include early-stage proof-of-concept studies. WHO requires all medical studies that test treatments on human...

  • Keeping sight of the goal.  // Nature Reviews Drug Discovery;Jul2006, Vol. 5 Issue 7, p525 

    The call by the World Health Organization for all clinical trials to be registered, and for information to be fully disclosed at the time of registration, has antagonized the pharmaceutical industry. More pragmatism could be needed if the important initiative to improve the transparency of...

  • The Latin American Ongoing Clinical Trial Register (LATINREC). Reveiz, Ludovic; Delgado, Martha B.; Urrutia, Gerard; Ortiz, Zulma; Dieguez, Marcelo Garcia; Marti-Carvajal, Arturo; Calgua, Erwin; Vieyra, Armando; Ciapponi, Agustin; Hidalgo, Ricardo; Pantoja, Tomas; Sanchez, Luis MarĂ­a; Pecino, Flora Martinez; Tristan, Mario // Revista Panamericana de Salud Publica;Jun2006, Vol. 19 Issue 6, p417 

    Although the need to request researchers and research institutions to register clinical trials at their inception in a publicly and universally accessible register has been considered for years (1), it has only recently become a major issue (2-4). The community and scientific world have been...

  • Industry anger over stringent trial disclosure requirements. Wadman, Meredith // Nature Reviews Drug Discovery;Jul2006, Vol. 5 Issue 7, p527 

    The article focuses on the argument over the World Health Organization's (WHO) request to register early stage trials. In an attempt to harmonize the process, the WHO has published universal standards for revealing data of clinical trials. The new standards endorse registration of all trials...

  • Drug trail double standards. Shah, Sonia // New Scientist;11/18/2006, Vol. 192 Issue 2578, p22 

    The article discusses why people who volunteer for clinical trials in the developing world do not get the same safeguards as those in the west. Drug companies export the last phases of clinical trials to developing countries. While the World Health Organization recognizes this to be a public...

  • Statement on publishing clinical trials in Indian biomedical journals. Satyanarayana, K.; Sharma, A.; Parikh, P.; Vijayan, V. K.; Sahu, D. K.; Nayak, B. K.; Gulati, R. K.; Parikh, M. N.; Singh, P. P.; Bavdekar, S. B.; Sreehari, U.; Sahni, P. // Indian Journal of Cancer;Apr-Jun2008, Vol. 45 Issue 2, p39 

    The article focuses on the launching of Clinical Trial Registry India in New Delhi on July 20, 2007. The launching of the online registry was hosted by the National Institute of Medical Statistics (NIMS) and the Indian Council of Medical Research (ICMR). The online registry was established to...

  • WHO calls for full disclosure of clinical trials. Woolston, Chris // Nature;4/23/2015, Vol. 520 Issue 7548, p411 

    The article reports that the World Health Organization (WHO) has called for full disclosure of clinical-trial results in biomedical research.

  • CULTURE CLUBS. Kibby, Matthew // Pharmaceutical Executive;Apr2006, Vol. 26 Issue 4, p106 

    The article reports on the role of ethics committees in a worldwide clinical trial. Their review systems are crucial to the development of global regulatory climate concerning patient-recruitment advertising. They are also consigned with ensuring protection, safety and welfare of clinical trial...

  • An international standard for disclosure of clinical trial information. Godlee, Fiona // BMJ: British Medical Journal (International Edition);5/13/2006, Vol. 332 Issue 7550, p1107 

    The article comments on the efforts to create a comprehensive registration for clinical trials. Current discussions center on negotiations with the pharmaceutical and medical devices industries about the information to be registered for which trials and when it should be done. An international ...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics